Viewing nowCombinationCrekanide Tablet 20/32 mg
Rosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
HanKook HyuTex Pharmaceutical Co., Ltd.

MFDS item code 202008723 · Approved 2020.12.11 · Insurance code 649105130
Dyslipidemia; treatment of hypertension and heart failure; inhibition of atherosclerosis progression and cardiovascular risk
This medication contains two active ingredients, Candesartan Cilexetil and Rosuvastatin, and is used for patients who need to take both medications simultaneously. Candesartan Cilexetil is primarily used for the treatment of essential hypertension and is effective in patients with heart failure with impaired left ventricular function who require or are intolerant to ACE inhibitors. Meanwhile, Rosuvastatin is utilized as a dietary adjunct for the management of lipid abnormalities, including primary and mixed hypercholesterolemia, and homozygous familial hypercholesterolemia. It also helps lower total cholesterol and LDL cholesterol, slowing the progression of atherosclerosis, and assisting in reducing the risk of cardiovascular diseases. Specifically, it is used for adults with high-sensitivity C-reactive protein and multiple cardiovascular risk factors to lower the risks of stroke, myocardial infarction, and arterial revascularization. In summary, this medication is effective in treating hypertension and cholesterol-related diseases concurrently.
This medicine is intended for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg, exercising particular caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of 2 weeks or longer, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Safety and efficacy have not been established in adolescents and children 18 years of age or younger. Safety and efficacy have not been established in adolescents and children 18 years of age or younger.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this medication or those with severely impaired liver function, patients with severe renal impairment, and women who are pregnant or breastfeeding. Caution should be exercised when using it in the elderly or patients with mildly impaired liver function, and patients with hyperkalemia due to the risk of adverse reactions. If symptoms of myalgia or muscle weakness occur, consult a physician immediately, and in severe cases, treatment may be discontinued. This medication can affect liver and kidney functions, so regular blood tests are needed to monitor liver enzymes and kidney function. When used with other antihypertensive or lipid-lowering drugs, as well as potassium-sparing diuretics, the risk of adverse reactions may increase due to interactions, so consultation with healthcare professionals is advised. Women planning to become pregnant should consult healthcare professionals before taking this medication and use adequate contraceptive methods. Dizziness or fatigue may occur, so caution is needed when driving or operating machinery. Keep out of reach of children, and it is not recommended to transfer the medication to other containers.
Headache, nasopharyngitis, localized infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, hyperglycemia, hyponatremia, hand fracture, hypoglycemia, nephrolithiasis, cough, headache, orthostatic dizziness, chest discomfort, nausea, musculoskeletal pain, neck pain, cataract, hyperglycemia, hyponatremia, dizziness, itching, nausea, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbance, decreased libido, forgetfulness, loss of appetite, increased appetite, tinnitus, taste disorder, erectile dysfunction, vascular edema, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, interstitial lung disease, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbance, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory decline, amnesia, cognitive impairment, confusion, severe muscle weakness, oculobulbar weakness, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, increased potassium, decreased sodium, ALT elevation, dizziness, weakness, fever, sensory disturbance, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, bleeding, anxiety, depression, drowsiness, dyspnea, rash, increased sweating, hematuria, pneumonia, femoral fracture, bruise, unstable angina, idiopathic pulmonary fibrosis, wet cough, exacerbation of hypertension, unstable blood pressure, vertigo, orthostatic vertigo, adrenal insufficiency, cerebral infarction, spondylitic myelopathy, musculoskeletal discomfort, shock, syncope, loss of consciousness, intestinal vascular edema, diarrhea, liver dysfunction, jaundice, urticaria, vascular edema, rhabdomyolysis, arthralgia, myalgia, low back pain, renal impairment, acute renal failure, interstitial pneumonia, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's effectiveness for a longer period.
Pink, round film-coated tablet
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
HanKook HyuTex Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.